These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11367950)

  • 1. [Approaches to systematic analysis of addiction management].
    Tretter F; Sonntag G
    Gesundheitswesen; 2001 Apr; 63(4):212-20. PubMed ID: 11367950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of cost-benefit analysis in integration projects on drug addiction].
    Ates T; Langer B; Erbas B; Tretter F; Wehner B
    Gesundheitswesen; 2005 Feb; 67(2):159-62. PubMed ID: 15747208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxicomania: death beyond risk. Analysis of cause-of-death in drug addicts].
    Jeanmonod R; Fryc O
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1643-8. PubMed ID: 2251480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current malaria situation in the Republic of Kazakhstan].
    Bismil'din FB; Shapieva ZhZh; Anpilova EN
    Med Parazitol (Mosk); 2001; (1):24-33. PubMed ID: 11548308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care reforms and managed care for substance abuse services: findings from eleven case studies.
    French MT; Dunlap LJ; Galinis DN; Rachal JV; Zarkin GA
    J Public Health Policy; 1996; 17(2):181-203. PubMed ID: 8764391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality assurance in heart surgery. General and personal concepts].
    Nollert G; Reichart B
    Herz; 1996 Dec; 21(6):383-8. PubMed ID: 9081907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality management in private practice. A nationwide survey in Germany].
    Obermann K; Müller P
    Urologe A; 2007 Aug; 46(8):851, 854-8, 860-3. PubMed ID: 17585358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the value of health-care services--the first step].
    Porzsolt F
    Med Klin (Munich); 2008 May; 103(5):321-4. PubMed ID: 18484218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention before care. Prevention by care].
    Brucker U; Hutzler D; Hasseler M
    Gesundheitswesen; 2004 May; 66(5):311-8. PubMed ID: 15141351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The qualified-detoxification-of-alcoholics procedure--in light of the development of guidelines for the treatment of substance-related disorders].
    Schmidt LG; Mundle G; Banger M; Stetter F; Soyka M; Veltrup C; Mann K
    Z Arztl Fortbild Qualitatssich; 2002 Jun; 96(5):295-300. PubMed ID: 12168549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.